共有 50 笔近期内部人交易记录记录，涉及 Tarsus Pharmaceuticals, Inc. (TARS), 包括 9 笔买入 和 38 笔卖出. 内部人买入总额为 RSU 奖励 内部人卖出总额为 $8.71M.
近期活跃的重要内部人包括 Neervannan Seshadri, Farrow Jeffrey S, Mottiwala Aziz. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — TARS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-20 |
Neervannan Seshadri |
Chief Operating Officer |
知情卖出 |
2,989 |
$66.75 |
$199.52K |
82,791 |
| 2026-03-19 |
Farrow Jeffrey S |
See Remarks |
知情卖出 |
2,186 |
$67.00 |
$146.46K |
43,316 |
| 2026-03-19 |
Mottiwala Aziz |
Chief Commercial Officer |
知情卖出 |
4,440 |
$67.00 |
$297.48K |
61,480 |
| 2026-03-19 |
Neervannan Seshadri |
Chief Operating Officer |
知情卖出 |
4,589 |
$67.00 |
$307.46K |
85,780 |
| 2026-03-19 |
Azamian Bobak R. |
President/ceo and Board Chair |
知情卖出 |
11,964 |
$67.00 |
$801.59K |
33,421 |
| 2026-03-19 |
Whitfield Dianne C. |
Chief Human Resources Officer |
知情卖出 |
4,174 |
$67.00 |
$279.66K |
35,028 |
| 2026-03-19 |
Wahl Bryan |
General Counsel |
知情卖出 |
4,231 |
$67.00 |
$283.48K |
63,959 |
| 2026-03-19 |
Lin Elizabeth Yeu |
Chief Medical Officer |
知情卖出 |
390 |
$67.00 |
$26.13K |
23,308 |
| 2026-03-18 |
Farrow Jeffrey S |
See Remarks |
知情卖出 |
2,133 |
$68.71 |
$146.56K |
45,502 |
| 2026-03-18 |
Mottiwala Aziz |
Chief Commercial Officer |
知情卖出 |
4,330 |
$68.71 |
$297.51K |
65,920 |
| 2026-03-18 |
Neervannan Seshadri |
Chief Operating Officer |
知情卖出 |
3,610 |
$68.71 |
$248.04K |
90,369 |
| 2026-03-18 |
Azamian Bobak R. |
President/ceo and Board Chair |
知情卖出 |
11,667 |
$68.71 |
$801.64K |
45,385 |
| 2026-03-18 |
Whitfield Dianne C. |
Chief Human Resources Officer |
知情卖出 |
4,071 |
$68.71 |
$279.72K |
39,202 |
| 2026-03-18 |
Wahl Bryan |
General Counsel |
知情卖出 |
4,125 |
$68.71 |
$283.43K |
68,190 |
| 2026-03-18 |
Lin Elizabeth Yeu |
Chief Medical Officer |
知情卖出 |
379 |
$68.71 |
$26.04K |
23,698 |
| 2026-03-17 |
Farrow Jeffrey S |
See Remarks |
知情卖出 |
2,111 |
$69.42 |
$146.55K |
47,635 |
| 2026-03-17 |
Mottiwala Aziz |
Chief Commercial Officer |
知情卖出 |
4,286 |
$69.42 |
$297.53K |
70,250 |
| 2026-03-17 |
Neervannan Seshadri |
Chief Operating Officer |
知情卖出 |
3,125 |
$69.42 |
$216.94K |
93,979 |
| 2026-03-17 |
Azamian Bobak R. |
President/ceo and Board Chair |
知情卖出 |
10,972 |
$69.42 |
$761.68K |
57,052 |
| 2026-03-17 |
Whitfield Dianne C. |
Chief Human Resources Officer |
知情卖出 |
4,029 |
$69.42 |
$279.69K |
43,273 |
| 2026-03-17 |
Wahl Bryan |
General Counsel |
知情卖出 |
4,084 |
$69.42 |
$283.51K |
72,315 |
| 2026-03-17 |
Lin Elizabeth Yeu |
Chief Medical Officer |
知情卖出 |
375 |
$69.42 |
$26.03K |
24,077 |
| 2026-03-16 |
Link William J Phd |
Director |
知情卖出 |
493 |
$69.75 |
$34.39K |
116,332 |
| 2026-03-15 |
Farrow Jeffrey S |
See Remarks |
期权行权（卖出） |
5,022 |
- |
- |
15,067 |
| 2026-03-15 |
Mottiwala Aziz |
Chief Commercial Officer |
期权行权（卖出） |
4,790 |
- |
- |
- |
| 2026-03-15 |
Neervannan Seshadri |
Chief Operating Officer |
期权行权（卖出） |
5,097 |
- |
- |
- |
| 2026-03-15 |
Azamian Bobak R. |
President/ceo and Board Chair |
期权行权（卖出） |
11,300 |
- |
- |
- |
| 2026-03-15 |
Whitfield Dianne C. |
Chief Human Resources Officer |
期权行权（卖出） |
4,463 |
- |
- |
- |
| 2026-03-15 |
Wahl Bryan |
General Counsel |
期权行权（卖出） |
4,790 |
- |
- |
- |
| 2026-03-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
期权行权（卖出） |
2,511 |
- |
- |
7,534 |
| 2026-03-05 |
Farrow Jeffrey S |
See Remarks |
限制性股票授予 (RSU) |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Mottiwala Aziz |
Chief Commercial Officer |
限制性股票授予 (RSU) |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Neervannan Seshadri |
Chief Operating Officer |
限制性股票授予 (RSU) |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Azamian Bobak R. |
President/ceo and Board Chair |
限制性股票授予 (RSU) |
60,776 |
- |
- |
60,776 |
| 2026-03-05 |
Whitfield Dianne C. |
Chief Human Resources Officer |
限制性股票授予 (RSU) |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Wahl Bryan |
General Counsel |
限制性股票授予 (RSU) |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Lin Elizabeth Yeu |
Chief Medical Officer |
限制性股票授予 (RSU) |
17,161 |
- |
- |
17,161 |
| 2026-03-04 |
Neervannan Seshadri |
Chief Operating Officer |
知情卖出 |
8,366 |
$76.67 |
$641.42K |
70,817 |
| 2026-02-18 |
Pyott David E I |
Director |
未知 |
7,000 |
$12.97 |
$90.79K |
- |
| 2026-02-18 |
Pyott David E I |
Director |
限制性股票授予 (RSU) |
3,729 |
- |
- |
3,729 |
| 2026-01-02 |
Whitfield Dianne C. |
Chief Human Resources Officer |
知情卖出 |
893 |
$82.93 |
$74.06K |
23,393 |
| 2025-12-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
知情卖出 |
557 |
$83.54 |
$46.53K |
857,991 |
| 2025-12-16 |
Lin Elizabeth Yeu |
Chief Medical Officer |
知情卖出 |
2,078 |
$79.50 |
$165.2K |
21,941 |
| 2025-12-16 |
Neervannan Seshadri |
Chief Operating Officer |
赠与（收到） |
475 |
- |
- |
475 |
| 2025-12-16 |
Whitfield Dianne C. |
Chief Human Resources Officer |
知情卖出 |
7,397 |
$80.10 |
$592.5K |
38,958 |
| 2025-12-15 |
Goodrich Katherine |
Director |
期权行权 |
2,233 |
- |
- |
2,233 |
| 2025-12-15 |
Link William J Phd |
Director |
知情卖出 |
4,766 |
$81.50 |
$388.43K |
- |
| 2025-12-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
期权行权（卖出） |
6,819 |
- |
- |
20,459 |
| 2025-12-04 |
Azamian Bobak R. |
President/ceo and Board Chair |
赠与（送出） |
51,885 |
- |
- |
1,750 |
| 2025-09-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
知情卖出 |
6,000 |
$55.37 |
$332.22K |
812,106 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
